L, K., MS, V., H, K., S, S., LL, E., & L, P. (2023). Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment. Scientific reports, 13(1), 12943. https://doi.org/10.1038/s41598-023-39694-2
Chicago Style (17th ed.) CitationL, Kuusalo, Venäläinen MS, Kirjala H, Saranpää S, Elo LL, and Pirilä L. "Development of Prediction Model for Alanine Transaminase Elevations During the First 6 months of Conventional Synthetic DMARD Treatment." Scientific Reports 13, no. 1 (2023): 12943. https://doi.org/10.1038/s41598-023-39694-2.
MLA (9th ed.) CitationL, Kuusalo, et al. "Development of Prediction Model for Alanine Transaminase Elevations During the First 6 months of Conventional Synthetic DMARD Treatment." Scientific Reports, vol. 13, no. 1, 2023, p. 12943, https://doi.org/10.1038/s41598-023-39694-2.